House Democrats Launch Price Negotiation Push: Extreme Plan Assures Strong Opposition
Executive Summary
Pelosi is moving forward with a draconian plan to limit US prices to an international benchmark. For now, the “bill” is a three-page outline subject to considerable legislative drafting – and so extreme as to rule out bipartisan compromise for the time being.
You may also be interested in...
BIO Stalwart Greenwood Announces Departure
Long-time CEO of the Biotechnology Innovation Organization will remain until after the 2020 election and help with the leadership transition.
PhRMA Continues Push For Medicare Part D Redesign In Drug Pricing Legislation
PhRMA exec discusses industry's opposition to generic mandates in formularies, its continued hope for rebate reform, and the damage Pelosi's bill could spawn even if it fails.
Drug Pricing Legislation In The US May Be Losing Momentum
House subcommittee hearing on drug price negotiation bill championed by Speaker Nancy Pelosi showcases strong Republican opposition, and Senate Finance Committee Chairman Chuck Grassley suggests his bill may not be ready for a floor vote until next year.